Norwest Venture Partners XVI, LP

13D and 13G Filings

13D/G filings
13D on 1 security
CIK
0001876200
All SEC filings
View on sec.gov
Issuer % of Class Filed
Schedule 13D · 1 security · may seek to influence control
MBX Biosciences, Inc. 13D/A
MBX · 55287L101
4.8% 9/30/2025
Event 9/26/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.